The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.

Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

The safety profile of the therapy was found to be favourable, without any serious adverse events linked to the treatment.

In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...